[1] 雷婷婷，赵荣生。雾化吸入给药的临床应用现状及研究进展[J].临床药学治疗杂志，2016，vol.14, no.3
[2] Inhalable Drugs Market Size, Share & Trends Analysis Report By Product (Aerosol, Dry Powder Formulation, Spray), By Application (Respiratory & Non-Respiratory Diseases), And Segment Forecasts, 2019 – 2026
[3] Jens Markus Borghardt etc. Inhaled Therapy in Respiratory Disease: The Complex Interplay of Pulmonary Kinetic Processes. Canadian Respiratory Journal, Volume 2018, Article ID 2732017, 11 pages
[4] Günther Hochhaus etc. Pharmacokinetics of Orally Inhaled Drug Products. The AAPS Journal, Vol. 17, No. 3, May 2015
[5]Huge D.C. Smyth, Anthony J. Hickey. Controlled Pulmonary Drug Delivery.
[6] P Högger, P Rohdewald. Binding kinetics of fluticasone propionate to the human glucocorticoid receptor. Steroids. 1994, vol 59, Pages 597-602
[7] David J. Alexander, etc. Association of Inhalation Toxicologists (AIT) Working Party Recommendation for Standard Delivered Dose Calculation and Expression in Non-Clinical Aerosol Inhalation Toxicology Studies with Pharmaceuticals. Inhalation Toxicology, 20:1179–1189, 2008
[8] STEPHEN I. RENNARD, etc. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J Appl Physiol (1985), 1986 Feb; 60(2):532-8
